We are live on
!
Find out more
AAP
Arax Advisory Partners Portfolio holdings
AUM
$15.1B
1-Year Est. Return
27.93%
This Fund
S&P 500
This Quarter
Est. Return
+16%
1 Year Est. Return
+27.93%
3 Year Est. Return
+64.69%
5 Year Est. Return
+64.07%
10 Year Est. Return
–
AUM
$15.1B
AUM Growth
+$11.5B
(+326%)
Cap. Flow
+$10.9B
Cap. Flow
% of AUM
71.99%
Top 10 Holdings %
Top 10 Hldgs %
18.25%
Holding
5,282
New
1,517
Increased
3,296
Reduced
222
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$331M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$324M |
| 3 |
NVIDIA
NVDA
|
+$260M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$219M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$172M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HIMU
iShares High Yield Muni Active ETF
HIMU
|
+$4.53M |
| 2 |
Vanguard Morningstar Small-Cap Value ETF
VBR
|
+$3.23M |
| 3 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$2.25M |
| 4 |
Vanguard Morningstar Mid-Cap Value ETF
VOE
|
+$2.21M |
| 5 |
Capital Group Growth ETF
CGGR
|
+$1.45M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.68% |
| 2 | Technology | 13.1% |
| 3 | Industrials | 6.81% |
| 4 | Financials | 6.59% |
| 5 | Energy | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BKV
4226
BKV Corp
BKV
$2.65B
| $12.6K | ﹤0.01% |
+460
| New | +$12.7K |
|
4227
Esquire Financial Holdings
ESQ
$1.36B
| $12.6K | ﹤0.01% |
105
-31
| -23% | -$3.43K |
|
4228
Compass Therapeutics
CMPX
$432M
| $12.5K | ﹤0.01% |
+5,725
| New | +$16.9K |
|
4229
Fortress Biotech
FBIO
$92.4M
| $12.5K | ﹤0.01% |
+4,086
| New | +$10.5K |
|
|
NVMI
4230
Nova
NVMI
$11.1B
| $12.5K | ﹤0.01% |
23
-9
| -28% | -$4.63K |
|
|
AKTS
4231
Aktis Oncology
AKTS
$1.43B
| $12.4K | ﹤0.01% |
+385
| New | +$7.91K |
|
4232
KRONOS Worldwide
KRO
$1.01B
| $12.4K | ﹤0.01% |
+1,958
| New | +$13.4K |
|
4233
Pro-Dex
PDEX
$200M
| $12.4K | ﹤0.01% |
+211
| New | +$12.3K |
|
|
SEVN
4234
Seven Hills Realty Trust
SEVN
$172M
| $12.3K | ﹤0.01% |
1,464
+1,455
| +16,167% | +$12.1K |
|
|
RPT
4235
Rithm Property Trust
RPT
$100M
| $12.3K | ﹤0.01% |
856
+855
| +85,500% | +$12.3K |
|
4236
Eos Energy Enterprises
EOSE
$1.19B
| $12.3K | ﹤0.01% |
+2,095
| New | +$14.6K |
|
4237
Core Laboratories
CLB
$567M
| $12.3K | ﹤0.01% |
1,052
+946
| +892% | +$13.5K |
|
|
UPB
4238
Upstream Bio Inc
UPB
$366M
| $12.3K | ﹤0.01% |
1,771
+1,694
| +2,200% | +$14.2K |
|
4239
Stoke Therapeutics
STOK
$2.04B
| $12.2K | ﹤0.01% |
+373
| New | +$12K |
|
|
FETH
4240
Fidelity Ethereum Fund
FETH
$1.31B
| $12.2K | ﹤0.01% |
+774
| New | +$15.9K |
|
4241
iShares MSCI USA Size Factor ETF
SIZE
$441M
| $12.1K | ﹤0.01% |
+68
| New | +$11.7K |
|
4242
Wetouch Technology
WETH
$15.3M
| $12.1K | ﹤0.01% |
+10,000
| New | +$15.3K |
|
4243
Annovis Bio
ANVS
$73.3M
| $12.1K | ﹤0.01% |
6,500
+2,500
| +63% | +$4.86K |
|
4244
3D Systems Corp
DDD
$545M
| $12.1K | ﹤0.01% |
3,997
+3,346
| +514% | +$9.12K |
|
4245
Third Coast Bancshares
TCBX
$752M
| $12K | ﹤0.01% |
298
+67
| +29% | +$2.61K |
|
4246
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.43B
| $12K | ﹤0.01% |
124
| – | – |
|
4247
Greenlight Captial
GLRE
$502M
| $11.9K | ﹤0.01% |
+738
| New | +$12.7K |
|
4248
Atlanticus Holdings
ATLC
$1.38B
| $11.9K | ﹤0.01% |
116
+110
| +1,833% | +$8.92K |
|
4249
AnaptysBio
ANAB
$1.67B
| $11.8K | ﹤0.01% |
+176
| New | +$10.7K |
|
4250
Establishment Labs
ESTA
$2.11B
| $11.8K | ﹤0.01% |
+138
| New | +$9.91K |
|
Similar funds
VIM
II
JFG
TWIM
IFP
SAM
WA
NMIFOAC
Arax Advisory Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Arax Advisory Partners held 5,282 positions worth $15.1B, up 326% from $3.54B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arax Advisory Partners deployed $10.9B of net new capital in Q2 2026, opening 1,517 new positions and adding to 3,296 existing holdings. Its largest new stake was ClearShares Piton Intermediate Fixed Income ETF: 984,286 shares worth $92M.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, down from 70% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was iShares High Yield Muni Active ETF, an estimated $4.53M trimmed.
- Arax Advisory Partners's largest Q2 2026 buy was ClearShares Piton Intermediate Fixed Income ETF: 984,286 shares worth $92M.
- Arax Advisory Partners added most to Apple in Q2 2026, an estimated $331M increase.
- Arax Advisory Partners's biggest Q2 2026 reduction was iShares High Yield Muni Active ETF, cutting an estimated $4.53M.
- Arax Advisory Partners fully exited Monroe Capital Corp in Q2 2026, selling an estimated $379K.
- Arax Advisory Partners's ten largest holdings make up 18% of its $15.1B portfolio in Q2 2026.
- Arax Advisory Partners opened 1,517 new positions and closed 78 in Q2 2026.
- Arax Advisory Partners's portfolio value rose 326% quarter-over-quarter to $15.1B.
Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.